Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi.org/10.1007/s00280-017-3463-x
In the original publication of the article, the second author name has been misspelled as L. E. Swart. The correct name should read as E. L. Swart.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Verheijen, R.B., Swart, E.L., Beijnen, J.H. et al. Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization. Cancer Chemother Pharmacol 86, 163 (2020). https://doi.org/10.1007/s00280-020-04090-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-020-04090-4